Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Anabolic steroid policy on course for March
“We are naturally pleased to have reached consensus with all parties regarding the outstanding issues."
Clarification and consensus reached with key stakeholders

An enhanced, zero-tolerance policy regarding the use of anabolic steroids in horseracing is on course for March 2, 2015 the British Horseracing Authority has announced.

The announcement follows clarification and consensus being reached with the National Trainers Federation (NTF), Thoroughbred Breeders' Association (TBA), and the Racehorse Owners Association (ROA) on certain elements relating to the revised policy.  

These issues led to a short delay in the policy's introduction, from January to March, and included the definition of "responsible person" - ie. the individual with the responsibility for ensuring that a horse is not administered with an anabolic steroid.

Jamie Stier, Director of Raceday Operations and Regulation for BHA, said: “The implementation of an entirely new and far reaching set of anti-doping Rules has been a complex process. We thank the ROA, NTF and TBA for their input throughout this process and their support for the principles behind the enhanced policy and the decision to delay the implementation.

“We are naturally pleased to have reached consensus with all parties regarding the outstanding issues and, while it was disappointing not to implement the policy on January 1, it was certainly the right decision not to rush the introduction of the Rules until consensus was reached.”

The policy aims to ensure that British Racing remains at the helm of tackling an issue that ranks amongst the biggest threats faced by all international sports.

Key elements of the policy include: that a racehorse must never be administered with an anabolic steroid at any time from birth to retirement; greater powers for BHA in terms of access for testing registered horses; the requirement for horses to be registered from a younger age, and for BHA to be aware of their whereabouts at all times; a more stringent 14 months stand-down period for horses found to have been administered with anabolic steroids; and greater controls on horses running in Great Britain from international jurisdictions.

BHA say that they will be releasing further details regarding the implementation of new rules ahead of the implementation date.

Become a member or log in to add this story to your CPD history

Survey launched to investigate EHV

News Story 1
 Zoetis has launched a new survey to identify management techniques for Equine Herpes Virus (EHV).

EHV is a contagious, airborne virus that can cause respiratory problems and severe diseases in horses and ponies. It spreads among horses over short distances, direct contact and through shared equipment.

The survey will explore current knowledge and management practices with EHV in the UK. It is quick to complete and participants could win one of 10 equine first aid kits.

Complete the survey here

Click here for more...
News Shorts
WSAVA launches pet travel guidance factsheet

A new pet travel guidance factsheet for veterinary professionals and caregivers has been developed by the WSAVA in collaboration with the World Veterinary Association.

The Dog and Cat Welfare During Transport factsheet provides step-by-step guidance for all stages of a journey, from pre-travel checklists to post-travel care.

Brachycephalic breeds or animals prone to travel-related anxiety are given special focus in this guide, which also provides links to IATA container regulation and WSAVA vaccination guidelines.